Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Denise Peterson

Editor-in-Chief, Regulatory & Policy Insights

Washington, DC

Denise oversees a group of US and European journalists covering biopharma regulatory and policy news and trends, primarily published in Pink Sheet. She also teams up with colleagues on strategic content initiatives affecting multiple Citeline publications as well as recruiting, training, website enhancements and collaborations with sales and marketing, and is involved in regulatory new product development.

She has had a colorful history as a reporter and senior editor on predecessor publications to Citeline’s current offerings, including Pink Sheet, Blue Sheet (NIH and public health programs), Beige Sheet (medical technology reimbursement) and Medicare Drug Focus. Her areas of particular expertise include Capitol Hill and health care reimbursement. Outside of the office, her interests include culinary history and she is a long-time literacy volunteer.

Latest From Denise Peterson

Maureen Kenny, 1963-2022

Kenny, a mainstay of our publications for three decades, has passed away in London.

Regulation BioPharmaceutical

Maureen Kenny, 1963-2022

Kenny, a mainstay of our publications for three decades, has passed away in London.

Regulation BioPharmaceutical

Maureen Kenny, 1963-2022

Kenny, a mainstay of our publications for three decades, has passed away in London.

Regulation BioPharmaceutical

Q4 Editor’s Picks: Clinical Trial Regulation

Coverage of clinical trial policy included commentary on rapid growth of the PD-1 pipeline by both US and China regulators; case studies and discussion of trial strategies including RWE, pediatric studies and decentralized trials; and US FDA commissioner-nominee Robert Califf’s R&D expertise.

Clinical Trials Real-World Evidence

Editor's Note: Please Help Pink Sheet Serve You Best

Please take our brief reader survey to help us better understand your content and delivery needs.

BioPharmaceutical

Editor’s Choice: Notable Pink Sheet Articles From Q3

A must-read selection of intriguing and popular articles posted in the Pink Sheet over the past three months.

Clinical Trials Market Access
See All
UsernamePublicRestriction

Register